Atlas Trials

Confirmatory Study of DSP-5423P in Patients With Schizophrenia

Clinical trial NCT02287584 · COMPLETED

Trial details

NCT number
NCT02287584
Sponsor
Sumitomo Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-12-01
Primary completion
2018-12-01
Enrollment
580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.